Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029514
Filing Date
2025-02-28
Accepted
2025-02-28 07:30:31
Documents
99
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K akro-20241231.htm   iXBRL 10-K 4301319
2 EX-4.2 akro-ex4_2.htm EX-4.2 33668
3 EX-19.1 akro-ex19_1.htm EX-19.1 116390
4 EX-23.1 akro-ex23_1.htm EX-23.1 3673
5 EX-31.1 akro-ex31_1.htm EX-31.1 17699
6 EX-31.2 akro-ex31_2.htm EX-31.2 17359
7 EX-32.1 akro-ex32_1.htm EX-32.1 15112
8 GRAPHIC img235453541_0.jpg GRAPHIC 45436
9 GRAPHIC img235453541_1.jpg GRAPHIC 511383
10 GRAPHIC img235453541_2.jpg GRAPHIC 59505
11 GRAPHIC img235453541_3.jpg GRAPHIC 541550
12 GRAPHIC img235453541_4.jpg GRAPHIC 1070419
13 GRAPHIC img235453541_5.jpg GRAPHIC 984819
14 GRAPHIC img235453541_6.jpg GRAPHIC 342272
15 GRAPHIC img235453541_7.jpg GRAPHIC 249916
16 GRAPHIC img235453541_8.jpg GRAPHIC 773946
17 GRAPHIC img235453541_9.jpg GRAPHIC 689830
18 GRAPHIC img235453541_10.jpg GRAPHIC 353530
19 GRAPHIC img235453541_11.jpg GRAPHIC 433872
20 GRAPHIC img235453541_12.jpg GRAPHIC 391762
21 GRAPHIC img235453541_13.jpg GRAPHIC 1162332
22 GRAPHIC img235453541_14.jpg GRAPHIC 393997
  Complete submission text file 0000950170-25-029514.txt   34830122

Data Files

Seq Description Document Type Size
23 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT akro-20241231.xsd EX-101.SCH 1568128
101 EXTRACTED XBRL INSTANCE DOCUMENT akro-20241231_htm.xml XML 3017222
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38944 | Film No.: 25682593
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)